跳至主要内容
临床试验/CTRI/2020/04/024609
CTRI/2020/04/024609尚未招募2 期

A prospective Randomized standard control clinical trial of Unani formulation in the management of Dermatomycoses

Aligarh Muslim University1 个研究点 分布在 1 个国家目标入组 104 人开始时间: 2020年4月27日最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
104
试验地点
1
主要终点
Unani formulation will be effective in treating Dermatomycoses

研究概览

简要总结

The purpose of this study is to determine and validate the safety and efficacy of Unani pharmacopeal formulation on the patients of fungal infection of the skin.   The Results of this study will be published in the Journals.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
13.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients with sign and symptoms of Dermatomycoses.

排除标准

  • Patient of Tinea capitis, Tinea ungium,impaired liver function, impaired renal function,Hypersensitivity of drugs, Malignancy, Epilepsy.
  • Patients on prolong medication for any systemic disorder,on systemic corticoseteroid, disease modyfiny agents.
  • Patients with secondary infection or any other infective disorder requiring long term treatment.Alcohalics, Drug Addicts,Pregnant or Lactating mother.

结局指标

主要结局

Unani formulation will be effective in treating Dermatomycoses

时间窗: 08 weeks

次要结局

  • Unani formulation will relieve of the symptomps of Dermacomycoses(08 weeks)

研究者

申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验